GlassScriptPhysician profile
Allison Raettig
NPI 1689185241
$1,731.59
in general payments reported to CMS, 2019-2025
16 companies · $607 in 2025
The $607 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $234 · 2023: $284 · 2024: $478 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $612.52 | 2021-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $227.26 | 2021-2025 | Ztlido |
| Medtronic, INC. | $163.97 | 2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $127.58 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Averitas Pharma INC. | $118.67 | 2024-2025 | Qutenza |
| Abbvie INC. | $105.83 | 2022-2025 | |
| Arbor Pharmaceuticals, INC. | $93.01 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $77.11 | 2023-2024 | Xeomin |
| Nevro Corp. | $48.45 | 2024 | Senza |
| Spr Therapeutics, INC | $42.89 | 2022-2024 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $33.17 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $20.85 | 2024 | Dysport |
| Ibsa Pharma INC. | $16.61 | 2023 | Tirosint, Licart |
| Avanos Medical | $15.90 | 2023 | Generator |
| Kyowa Kirin, INC. | $14.15 | 2024 | Crysvita |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Raettig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.